The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain
Protein Science · 2025
DOI: 10.1002/pro.70022 ↗At a glance
Journal article in Protein Science, 2025. Written by Liam Haas-Neill and 7 co-authors. Institution: Department of Physics, University of Toronto, Toronto, Ontario, Canada. Major MEDLINE topics: STAT5 Transcription Factor, Molecular Dynamics Simulation, src Homology Domains. Cited 1 times so far (Crossref); 98 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Digital Research Alliance of Canada, Natural Sciences and Engineering Research Council of Canada, Alliance de recherche numérique du Canada.
Abstract (original language)
The point mutation N642H of the signal transducer and activator of transcription 5B (STAT5B) protein is associated with aggressive and drug‐resistant forms of leukemia. This mutation is thought to promote cancer due to hyperactivation of STAT5B caused by increased stability of the active, parallel dimer state. However, the molecular mechanism leading to this stabilization is not well understood as there is currently no structure of the parallel dimer. To investigate the mutation's mechanism of action, we conducted extensive all‐atom molecular dynamics simulations of multiple oligomeric forms of both STAT5B and STAT5B N642H , including a model for the parallel dimer. The N642H mutation directly affects the hydrogen bonding network within the phosphotyrosine (pY)‐binding pocket of the parallel dimer, enhancing the pY‐binding interaction. The simulations indicate that apo STAT5B is highly flexible, exploring a diverse conformational space. In contrast, apo STAT5B N642H accesses two distinct conformational states, one of which resembles the conformation of the parallel dimer. The simulation predictions of the effects of the mutation on structure and dynamics are supported by the results of hydrogen‐deuterium exchange (HDX) mass spectrometry measurements carried out on STAT5B and STAT5B N642H in which a phosphopeptide was used to mimic the effects of parallel dimerization on the SH2 domain. The molecular‐level information uncovered in this work contributes to our understanding of STAT5B hyperactivation by the N642H mutation and could help pave the way for novel therapeutic strategies targeting this mutation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physics, University of Toronto, Toronto, Ontario, Canada.
- Department of Chemical and Physical Sciences, University of Toronto Mississauga, Mississauga, Ontario, Canada.
- Department of Chemistry, York University, Toronto, Ontario, Canada.
- Department of Chemistry, University of Toronto, Toronto, Ontario, Canada.
ORCID profiles: Liam Haas-Neill, Deniz Meneksedag-Erol, Masha Novoselova, Elvin D de Araujo, Derek J Wilson, Sarah Rauscher
Funding
- Digital Research Alliance of Canada
- Natural Sciences and Engineering Research Council of Canada
- Alliance de recherche numérique du Canada
Cite
APA
Haas-Neill, L., Meneksedag-Erol, D., Chaudhry, A., Novoselova, M., Ashraf, Q. F., de Araujo, E. D., Wilson, D. J., & Rauscher, S. (2025). The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain. Protein Science. https://doi.org/10.1002/pro.70022
Vancouver
Haas-Neill L, Meneksedag-Erol D, Chaudhry A, Novoselova M, Ashraf QF, de Araujo ED, et al. The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain. Protein Science. 2025. doi:10.1002/pro.70022
BibTeX
@article{HaasNeill2025,
author = {Haas-Neill, Liam and Meneksedag-Erol, Deniz and Chaudhry, Ayesha and Novoselova, Masha and Ashraf, Qirat F and de Araujo, Elvin D and Wilson, Derek J and Rauscher, Sarah},
title = {The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain},
journal = {Protein Science},
year = {2025},
doi = {10.1002/pro.70022}
}
EUVIMED